HSE to extend Soliris drug to PNH & aHUS patients – Deering
4th February 2015 - Fine Gael Press Office
Fine Gael Carlow/ Kilkenny TD, Pat Deering, has today (Wednesday) welcomed confirmation from the HSE that they are to extend access to the drug Eculizumab (trading as Soliris), for patients with the conditions Paroxysmal Nocturnal Hemoglobinuria (PNH) and atypical Haemolytic Uraemic (aHUS).
“I have been advocating for this drug to be State funded ever since I heard the story of Ballinakill woman Mary Gorman who has PNH, a very rare and debilitating disease.
Related news
Dublin needs urgent infrastructure investment - time to publish Dublin City Taskforce report – Geoghegan
The Dublin City Taskforce implementation report must be published immediately, following a major new study which estimates that €70 billion…
28th May 2025Tánaiste appoints Paula Butterly TD Fine Gael Spokesperson for Regional Development
Tánaiste and Fine Gael leader Simon Harris has appointed Paula Butterly TD Fine Gael Spokesperson for Regional Development. An Tánaiste…
26th May 2025Future of postal network must be guaranteed - Byrne
Increased funding must be made available to secure the future of the Irish postal network, said a Fine Gael Senator.…
26th May 2025